JP2008503712A5 - - Google Patents

Download PDF

Info

Publication number
JP2008503712A5
JP2008503712A5 JP2007515968A JP2007515968A JP2008503712A5 JP 2008503712 A5 JP2008503712 A5 JP 2008503712A5 JP 2007515968 A JP2007515968 A JP 2007515968A JP 2007515968 A JP2007515968 A JP 2007515968A JP 2008503712 A5 JP2008503712 A5 JP 2008503712A5
Authority
JP
Japan
Prior art keywords
acid sequence
group
seq
polypeptide
nos
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007515968A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008503712A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2005/052875 external-priority patent/WO2005124342A2/en
Publication of JP2008503712A publication Critical patent/JP2008503712A/ja
Publication of JP2008503712A5 publication Critical patent/JP2008503712A5/ja
Pending legal-status Critical Current

Links

JP2007515968A 2004-06-21 2005-06-21 骨関節炎治療の方法及び手段 Pending JP2008503712A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58156804P 2004-06-21 2004-06-21
PCT/EP2005/052875 WO2005124342A2 (en) 2004-06-21 2005-06-21 Methods and means for treatment of osteoarthritis

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2011171363A Division JP5595989B2 (ja) 2004-06-21 2011-08-04 骨関節炎治療の方法及び手段
JP2011171061A Division JP2012021995A (ja) 2004-06-21 2011-08-04 骨関節炎治療の方法及び手段

Publications (2)

Publication Number Publication Date
JP2008503712A JP2008503712A (ja) 2008-02-07
JP2008503712A5 true JP2008503712A5 (cg-RX-API-DMAC7.html) 2008-07-31

Family

ID=35510369

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2007515968A Pending JP2008503712A (ja) 2004-06-21 2005-06-21 骨関節炎治療の方法及び手段
JP2011171061A Pending JP2012021995A (ja) 2004-06-21 2011-08-04 骨関節炎治療の方法及び手段
JP2011171363A Expired - Fee Related JP5595989B2 (ja) 2004-06-21 2011-08-04 骨関節炎治療の方法及び手段

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2011171061A Pending JP2012021995A (ja) 2004-06-21 2011-08-04 骨関節炎治療の方法及び手段
JP2011171363A Expired - Fee Related JP5595989B2 (ja) 2004-06-21 2011-08-04 骨関節炎治療の方法及び手段

Country Status (5)

Country Link
US (4) US20070004658A1 (cg-RX-API-DMAC7.html)
EP (3) EP1759203A2 (cg-RX-API-DMAC7.html)
JP (3) JP2008503712A (cg-RX-API-DMAC7.html)
ES (2) ES2427136T3 (cg-RX-API-DMAC7.html)
WO (1) WO2005124342A2 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1759203A2 (en) 2004-06-21 2007-03-07 Galapagos N.V. Methods and means for treatment of osteoarthritis
US7485468B2 (en) * 2004-10-15 2009-02-03 Galapagos Bv Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
US8673268B2 (en) 2004-10-15 2014-03-18 Galapagos N.V. Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
ES2310469B1 (es) * 2007-03-08 2009-11-16 Consejo Superior Investig. Cientificas Uso compuestos inhibidores actividad snail1 en elaboracion composiciones farmaceuticas utiles para tratamiento de condrodisplasias, procedimiento identificacion compuestos inhibidores, dichas composiciones farmaceuticas, procedimiento diagnostico condrodisplasias y aplicaciones.
WO2008112266A1 (en) * 2007-03-12 2008-09-18 Thomas Lally Cartilage stimluaiting bio-material composition and method
JP2010538244A (ja) 2007-06-20 2010-12-09 ガラパゴス・ナムローゼ・フェンノートシャップ 骨及び関節の変性疾患の治療に有用な分子標的及び化合物並びにその同定方法
US8501449B2 (en) * 2007-12-04 2013-08-06 Proteon Therapeutics, Inc. Recombinant elastase proteins and methods of manufacturing and use thereof
JO3041B1 (ar) 2008-07-25 2016-09-05 Galapagos Nv مركبات جديدة مفيدة لمعالجة الأمراض التنكسية والالتهابية
TWI462920B (zh) 2009-06-26 2014-12-01 葛萊伯格有限公司 用於治療退化性及發炎疾病之新穎化合物
JO3030B1 (ar) 2009-06-26 2016-09-05 Galapagos Nv مركب جديد مفيد لمعالجة الامراض التنكسية والالتهابات
RU2405490C1 (ru) * 2009-06-29 2010-12-10 Анатолий Дмитриевич Олейник Способ превентивного лечения рецидива болевого синдрома при хирургических вмешательствах на поясничных межпозвонковых дисках
CA2830882C (en) 2011-03-22 2021-03-16 Dinesh Barawkar Substituted fused tricyclic compounds, compositions and medicinal applications thereof
AR086042A1 (es) 2011-04-28 2013-11-13 Galapagos Nv Compuesto util para el tratamiento de enfermedades degenerativas e inflamatorias y composicion farmaceutica
US9593115B2 (en) 2012-09-21 2017-03-14 Advinus Therapeutics Ltd. Substituted fused tricyclic compounds, compositions, and medicinal applications thereof
US9556148B2 (en) 2013-08-07 2017-01-31 Cadila Healthcare Limited N-cyanomethylamides as inhibitors of janus kinase
GB201401086D0 (en) 2014-01-23 2014-03-12 Galapagos Nv Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GB201402070D0 (en) 2014-02-07 2014-03-26 Galapagos Nv Pharmaceutical compositions for the treatment of inflammatory disorders
GB201402071D0 (en) 2014-02-07 2014-03-26 Galapagos Nv Novel salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders
KR101710127B1 (ko) 2014-08-29 2017-02-27 한화제약주식회사 야누스인산화효소 억제제로서의 치환된 N-(피롤리딘-3-일)-7H-피롤로[2,3-d]피리미딘-4-아민
GB201512733D0 (en) * 2015-07-20 2015-08-26 Genagon Therapeutics Ab Therapeutic agents for treating conditions associated with elevated GDF15
GB201700567D0 (en) 2017-01-12 2017-03-01 Genagon Therapeutics Ab Therapeutic agents
JP2021520484A (ja) * 2018-04-03 2021-08-19 サノフイＳａｎｏｆｉ ラテラルフロー免疫アッセイストリップ装置
GB201808575D0 (en) 2018-05-24 2018-07-11 Galapagos Nv Methods for the treatment of psoriatic arthrits

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US5354844A (en) 1989-03-16 1994-10-11 Boehringer Ingelheim International Gmbh Protein-polycation conjugates
US5693622A (en) 1989-03-21 1997-12-02 Vical Incorporated Expression of exogenous polynucleotide sequences cardiac muscle of a mammal
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5264618A (en) 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
AU4769893A (en) 1992-07-17 1994-02-14 Ribozyme Pharmaceuticals, Inc. Method and reagent for treatment of animal diseases
FR2714830B1 (fr) 1994-01-10 1996-03-22 Rhone Poulenc Rorer Sa Composition contenant des acides nucléiques, préparation et utilisations.
FR2715847B1 (fr) 1994-02-08 1996-04-12 Rhone Poulenc Rorer Sa Composition contenant des acides nucléiques, préparation et utilisations.
FR2727679B1 (fr) 1994-12-05 1997-01-03 Rhone Poulenc Rorer Sa Nouveaux agents de transfection et leurs applications pharmaceutiques
FR2730637B1 (fr) 1995-02-17 1997-03-28 Rhone Poulenc Rorer Sa Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
US20050043234A1 (en) * 1996-10-16 2005-02-24 Deisher Theresa A. Novel FGF homologs
US6413776B1 (en) 1998-06-12 2002-07-02 Galapagos Geonomics N.V. High throughput screening of gene function using adenoviral libraries for functional genomics applications
WO2000044722A1 (en) 1999-01-29 2000-08-03 Chugai Seiyaku Kabushiki Kaisha Chondrongenesis promotors and indolin-2-one derivatives
US6706267B1 (en) * 1999-09-14 2004-03-16 Arkion Life Sciences Llc Glucosamine and egg for reducing inflammation
US7332337B2 (en) 2000-05-16 2008-02-19 Galapagos Nv Viral vectors having tissue tropism for T-lymphocytes, B- and mast cells
EP1287021A2 (en) * 2000-05-18 2003-03-05 Bayer Aktiengesellschaft Human galanin receptor-like g protein coupled receptor
US7235233B2 (en) 2000-09-26 2007-06-26 Crucell Holland B.V. Serotype 5 adenoviral vectors with chimeric fibers for gene delivery in skeletal muscle cells or myoblasts
AU2002253104A1 (en) 2001-03-07 2002-09-19 Galapagos Genomics B.V. Adenoviral library assay for e2f regulatory genes and methods and compositions for screening compounds
JPWO2002087620A1 (ja) 2001-04-27 2004-08-12 中外製薬株式会社 軟骨形成促進剤
US20030068779A1 (en) * 2001-05-09 2003-04-10 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1921088B1 (en) * 2001-05-11 2014-10-08 Amgen Inc. Peptides and related molecules that bind to tall-1
KR20020096368A (ko) * 2001-06-19 2002-12-31 주식회사 티지 바이오텍 연골세포의 분화촉진, 연골세포의 탈분화 억제 또는탈분화된 연골세포의 재분화 촉진제, 그것의 스크리닝방법 및 그것을 이용한 연골세포의 제조방법
JP2005503792A (ja) 2001-08-22 2005-02-10 ガラパゴス・ジェノミックス・ナムローゼ・フェンノートシャップ ハイ・スループット・スクリーニングにおいて同定される骨の恒常性のモジュレーター
US20030198627A1 (en) 2001-09-01 2003-10-23 Gert-Jan Arts siRNA knockout assay method and constructs
AU2002367732A1 (en) * 2001-10-31 2003-09-09 Children's Hospital Medical Center Method for diagnosis and treatment of rheumatoid arthritis
AU2003209340A1 (en) * 2002-01-18 2003-09-02 Bristol-Myers Squibb Company Predictor sets for tyrosine kinase pathways
JP2004000209A (ja) * 2002-04-26 2004-01-08 Sumitomo Pharmaceut Co Ltd 軟骨障害マーカー及びその利用
EP1604202A2 (en) * 2003-03-11 2005-12-14 Bayer HealthCare AG Diagnostics and therapeutics for diseases associated with phosphodiesterase 1a (pde1a)
AU2003224132A1 (en) 2003-04-24 2004-11-19 Galapagos Genomics N.V. Effective sirna knock-down constructs
WO2005063983A1 (en) * 2003-12-29 2005-07-14 Galapagos Genomics N.V. Modulators of bone homeostasis identified in a high-throughput screen
EP1759203A2 (en) * 2004-06-21 2007-03-07 Galapagos N.V. Methods and means for treatment of osteoarthritis

Similar Documents

Publication Publication Date Title
JP2008503712A5 (cg-RX-API-DMAC7.html)
Zhu et al. IL-13 secreted by ILC2s promotes the self-renewal of intestinal stem cells through circular RNA circPan3
JP2007534725A5 (cg-RX-API-DMAC7.html)
JP2008516593A5 (cg-RX-API-DMAC7.html)
US20250270555A1 (en) Organic compositions to treat beta-catenin-related diseases
KR20210076082A (ko) Rna를 편집하기 위한 방법 및 조성물
Trovato et al. Interleukin-6 signalling as a valuable cornerstone for molecular medicine
EP3679145A2 (en) Compositions and methods for chimeric ligand receptor (clr)-mediated conditional gene expression
EP3655961A1 (en) Cell atlas of healthy and diseased barrier tissues
JP2011515653A (ja) 神経変性疾患の治療に有用な標的配列及びそれらの同定方法
JP2017523984A (ja) 拮抗性抗ｏｘ４０ｌ抗体およびそれらの使用方法
US20230059921A1 (en) Methods and compositions for diagnostically-responsive ligand-targeted delivery of therapeutic agents
US12194010B2 (en) Methods and compositions to prevent and treat disorders associated with mutations in the ODC1 gene
TW201729841A (zh) 用於治療自體免疫疾病及癌症之組成物及方法
JP2010538244A (ja) 骨及び関節の変性疾患の治療に有用な分子標的及び化合物並びにその同定方法
JP2016522675A (ja) 上皮間葉移行に関連した疾患の治療において有用な分子標的及び前記標的のインヒビター
CA3150095A1 (en) IMMUNE CELL ENGINEERING FOR EX VIVO CELLULAR THERAPY APPLICATIONS
JP2008502355A5 (cg-RX-API-DMAC7.html)
JP6895175B2 (ja) エクソソーム分泌阻害剤
KR20230023612A (ko) 조작된 올리고뉴클레오티드를 사용한 표적화된 억제
US20240201168A1 (en) Composition for diagnosis or treatment of anticancer drug resistance
EP3914071A1 (en) Human genomic construct reporter cells and mouse models to screen therapeutics against microglia-expressed disease associated genes
Wang et al. Progress in understanding the relationship between circular RNAs and neurological disorders
Gambari et al. Decoy oligodeoxyribonucleotides and peptide nucleic acids–DNA chimeras targeting nuclear factor kappa-B: Inhibition of IL-8 gene expression in cystic fibrosis cells infected with Pseudomonas aeruginosa
US20250283164A1 (en) Rna-binding by transcription factors